Engineered for Stability: The Advantage of Bilayer Technology
Our Levocetirizine and Montelukast combination formulation utilizes advanced Bilayer Tablet Technology to ensure maximum product integrity and therapeutic effect. We recognize that Montelukast is a sensitive molecule that can degrade when in direct physical contact with other active ingredients over time. By physically separating Montelukast and Levocetirizine into two distinct, independent layers within a single tablet, our bilayer design prevents chemical interaction. This ensures that both critical components remain stable and potent throughout the product's shelf-life, delivering consistent, reliable relief to the patient with every dose.
This advanced formulation combines three potent active ingredients to provide comprehensive relief in moderate to severe painful inflammatory conditions. It synergizes the established analgesic and anti-inflammatory properties of Aceclofenac and Paracetamol with the powerful enzymatic action of Serratiopeptidase.
This advanced formulation addresses Gastroesophageal Reflux Disease (GERD) complicated by dysmotility through a state-of-the-art Tablet-in-Capsule delivery system.